Localisation of suspected pathology | Number of PET + lesions | Number of CT + lesions | CT appearance | Pathology unrelated to prostate cancer | Number of patients | Σ distant metastases |
---|---|---|---|---|---|---|
Paraaortal LN | 6 (mean SUVmax 5.8 g/ml) | 6 (mean short axis 13 mm) | Oval-rounded shape | 6 | 6 (4 solitary, 2 conglomerates) | |
Mediastinal/hilar LN | 8 (mean SUVmax 3.7 g/ml) | 8 (mean short axis 10 mm) | Oval-rounded shape | 8 | 8 (6 solitary, 2 conglomerates) | |
Axillary LN | 1 (SUVmax 9.0 g/ml) | 1 (short axis 10 mm) | Rounded shape | 1 | 1 | |
Cervical LN | 2 (mean SUVmax 5.6 g/ml) | 2 (mean short axis 10 mm) | Rounded shape | 1 | 2 (2 conglomerates) | |
Skeletal | 20 (mean SUVmax 7.1 g/ml) | 20 | Sclerotic | 4 | 20 | |
Liver | 1 (SUVmax 14.3 g/ml) | 1 | Hypoattenuating mass | HCC | 1 | - |
Kidney | 1 (SUVmax 14.2 g/ml) | 1 | Heterogeneous mass | RCC | 1 | - |
Σ | 39 | 39 | 22a | 37 |